Jatenzo vs Tlando: Which Oral Testosterone Replacement Therapy Is Right for You?

Understanding Oral Testosterone Replacement Therapy

Oral testosterone has historically struggled with poor bioavailability and liver toxicity concerns. Traditional oral formulations underwent extensive first-pass hepatic metabolism, leading to inadequate testosterone levels and potential hepatotoxicity.

The FDA approval of Jatenzo (2019) and Tlando (2022) changed this landscape dramatically. Both use testosterone undecanoate in lipid-based formulations that enable lymphatic absorption, bypassing portal circulation and minimizing liver exposure.

This represents a genuine needle-free alternative for men with hypogonadism who want to avoid injections or topical applications.

First-Pass Hepatic Metabolism is the process where oral medications are absorbed from the gastrointestinal tract and transported directly to the liver before entering systemic circulation, reducing drug bioavailability and increasing hepatotoxicity risk.

What Is Jatenzo (Testosterone Undecanoate)?

Jatenzo is the first FDA-approved oral testosterone undecanoate using self-emulsifying drug delivery system (SEDDS) technology¹. It was approved in March 2019 for testosterone replacement therapy in adult males with hypogonadism.

How Jatenzo Works

The medication uses a lipid-based SEDDS formulation that enables absorption through the intestinal lymphatic system rather than the portal vein¹. This lymphatic route bypasses first-pass liver metabolism, dramatically reducing hepatotoxicity risk while maintaining therapeutic testosterone levels.

You take Jatenzo twice daily with food—specifically meals containing approximately 30 grams of fat for optimal absorption. Taking it with a 15-gram fat meal decreases exposure by roughly 25% compared to a 30-gram fat meal¹.

Jatenzo Dosing and Titration

Jatenzo starts at 237 mg twice daily (morning and evening). Based on serum testosterone levels measured 6 hours after your morning dose, your physician can titrate between 158 mg and 396 mg twice daily¹.

This titration capability allows personalized optimization—a key advantage over fixed-dose alternatives.

Clinical Evidence for Jatenzo

In clinical trials, 87% of patients achieved eugonadal testosterone levels at the primary endpoint, with this efficacy sustained over 2 years¹. More specifically, 87.3% of men attained normal testosterone values within 120 days².

Beyond testosterone normalization, Jatenzo demonstrated clinically meaningful improvements in psychosexual function sustained through 24 months¹.

Self-Emulsifying Drug Delivery System (SEDDS) is a lipid-based formulation that spontaneously forms fine oil-in-water emulsions in the gastrointestinal tract, enabling absorption through intestinal lymphatics and bypassing first-pass liver metabolism.

What Is Tlando (Testosterone Undecanoate)?

Tlando received FDA approval in March 2022 as the second oral testosterone undecanoate product. Like Jatenzo, it uses lipid-based formulation for lymphatic absorption.

How Tlando Works

Tlando employs SEDDS technology to achieve self-emulsification in the GI tract, facilitating absorption through intestinal lymphatics and bypassing hepatic first-pass metabolism³.

The prescribing information emphasizes that Tlando is not substitutable with other oral testosterone undecanoate products, including Jatenzo⁴. Formulation differences between branded products mean they cannot be interchanged without medical supervision.

Tlando Dosing Protocol

Tlando is dosed at 225 mg (two 112.5 mg capsules) twice daily—once in the morning and once in the evening with food⁴.

Unlike Jatenzo's titratable approach, Tlando uses a fixed dose. Your doctor monitors serum testosterone 3-4 weeks after starting treatment, checking levels 8-9 hours after your morning dose. If levels fall below 300 ng/dL or exceed 1,080 ng/dL, Tlando should be discontinued⁴.

This all-or-nothing approach means less dosing flexibility compared to Jatenzo's titration range.

Food Requirements for Tlando

Tlando must be taken with food, but the prescribing information notes that moderate-fat meals do not significantly impact pharmacokinetics compared to high-fat or low-fat meals⁵.

This offers more meal flexibility than Jatenzo's stricter 30-gram fat requirement.

Jatenzo vs Tlando: Head-to-Head Comparison

Absorption and Bioavailability

Both medications use SEDDS formulation for lymphatic absorption, but Jatenzo was the first FDA-approved oral testosterone undecanoate using this technology¹.

The key difference: Jatenzo's bioavailability is notably affected by meal fat content (25% reduction with 15g vs 30g fat meals), while Tlando shows less sensitivity to fat content variations⁵.

If you have trouble consistently eating high-fat meals twice daily, Tlando's flexibility may be advantageous. If you're disciplined about meal composition, Jatenzo's stricter requirements shouldn't pose problems.

Dosing Schedules and Administration

Both require twice-daily dosing with food—there's no winner here for convenience.

The critical difference is titration. Jatenzo allows dose adjustment from 158-396 mg twice daily based on your testosterone response¹. This personalization can optimize your levels and potentially minimize side effects.

Tlando's fixed 225 mg dose simplifies prescribing but removes customization options. If the fixed dose doesn't achieve target levels (300-1,080 ng/dL), your only option is discontinuation⁴.

Winner: Jatenzo for personalized optimization.

Effectiveness and Testosterone Levels

Jatenzo's clinical trials provide more comprehensive efficacy data. In phase 3 studies involving 221 and 321 patients, 87% achieved eugonadal testosterone levels, with benefits sustained through 2-year follow-up¹.

Tlando's clinical program included Study 18-001 with 138 patients treated for approximately 4 months⁴. While it demonstrated ability to achieve therapeutic testosterone levels (300-1,080 ng/dL target range), published data lacks the long-term follow-up and specific success percentages available for Jatenzo.

Both medications reliably restore testosterone to normal ranges when properly administered with food. The difference lies in the depth and duration of clinical evidence supporting long-term efficacy.

Winner: Jatenzo for superior clinical evidence and demonstrated 2-year durability.

Eugonadal refers to the state of having normal, healthy testosterone levels within the physiological range, typically 300-1,000 ng/dL in adult males, indicating adequate testicular function.

Side Effect Profiles

Cardiovascular Considerations

Both medications carry warnings for blood pressure elevation—a class effect of testosterone therapy that's particularly notable with oral formulations.

Jatenzo includes a boxed warning for blood pressure increases, with mean systolic BP rising 3-5 mmHg in clinical trials¹. Ongoing blood pressure monitoring is required throughout treatment.

Tlando similarly lists high blood pressure as a common adverse reaction (≥2% incidence)³, though specific mean BP changes aren't detailed in available prescribing information.

Both medications require careful patient selection and monitoring if you have existing cardiovascular risk factors. Neither product has a clear safety advantage in this category based on available data.

Common Side Effects

Jatenzo's most frequent adverse events include the blood pressure increases noted above, plus GI upset (generally mild), polycythemia, and standard testosterone-related effects¹.

Tlando reports increased blood prolactin, high blood pressure, increased hematocrit, and upper respiratory tract infections as adverse reactions occurring in ≥2% of patients³.

The side effect profiles are comparable, with both medications demonstrating generally good tolerability in clinical trials.

Liver Safety Profile

This is where oral testosterone undecanoate shines compared to historical alkylated oral testosterone formulations.

Jatenzo showed no clinically significant hepatotoxicity in phase 3 trials involving 221 and 321 patients, with no concerning liver function test changes over 2 years of treatment in 81 patients⁶. Rare transient ALT/AST elevations occurred (less than 3× upper limit of normal), but all with normal bilirubin.

Tlando's lymphatic absorption similarly bypasses first-pass liver metabolism³, providing theoretical hepatic safety advantages, though specific hepatotoxicity incidence rates aren't detailed in available sources.

Both medications represent a massive improvement over legacy oral testosterone products that required 17-alpha-alkylation and carried significant liver toxicity risks.

Winner: Tie—both offer excellent liver safety through lymphatic absorption, with Jatenzo having slightly more published long-term safety data.

Polycythemia is an abnormal increase in red blood cell production, which can occur as a side effect of testosterone therapy and may increase blood viscosity and thrombotic risk.

Cost Comparison and Insurance Coverage

This is where the comparison gets challenging due to limited transparent pricing data.

Jatenzo's retail pricing varies by strength: approximately $1,200 for 120 capsules of 158 mg and $2,400 for 120 capsules of 237 mg⁷. At twice-daily dosing, that's a 30-day supply costing $1,200-$2,400 depending on your prescribed dose.

Tlando pricing isn't publicly disclosed in available sources, though as a newer branded medication (approved 2022), it likely carries similar premium pricing.

Insurance coverage exists for both medications, but formulary placement, tier levels, copays, and prior authorization requirements vary significantly by plan. Neither manufacturer prominently advertises patient savings programs in publicly available materials.

The reality: both are expensive branded medications. Your out-of-pocket cost will depend almost entirely on your insurance formulary. Before choosing based on price, verify coverage with your specific insurance plan.

Winner: Insurance-dependent—check your formulary before deciding.

Patient Experiences and Compliance

Twice-daily dosing with food presents adherence challenges for both medications. You need to remember morning and evening doses, time them with appropriately sized meals, and maintain consistency to keep testosterone levels stable.

Jatenzo's stricter fat requirements (30g meals for optimal absorption) add complexity but also provide clear guidance. If you're someone who prefers precise protocols, this structure can actually improve compliance.

Tlando's flexible food requirements reduce one barrier to adherence—you don't need to meticulously track meal fat content.

The lack of dose titration with Tlando simplifies the regimen (no adjustments), but it also means you can't optimize if you're experiencing side effects at the fixed dose. Jatenzo's titration capability allows working with your doctor to find your optimal dose, potentially improving tolerability and continuation.

Jatenzo's published data includes clinically meaningful improvements in psychosexual function sustained through 24 months¹—suggesting that patients who stick with it experience quality of life benefits that support long-term adherence.

Who Should Choose Jatenzo?

Choose Jatenzo if:

• You want the most extensive clinical evidence supporting long-term efficacy (2-year data with 87% achieving normal testosterone levels)
• You value dose personalization and the ability to titrate for optimal testosterone levels and minimal side effects
• You're disciplined about meal timing and composition (30g fat with each dose)
• You prioritize psychosexual function improvements backed by clinical trial data
• Your insurance provides comparable coverage to Tlando (making clinical evidence the differentiator)

Jatenzo is the better choice for most patients seeking oral TRT because it offers proven efficacy, flexible dosing, and the most robust published clinical data supporting both effectiveness and safety over 2+ years.

Who Should Choose Tlando?

Choose Tlando if:

• Your insurance formulary strongly favors Tlando (significantly lower copay or no prior authorization vs. Jatenzo)
• You struggle with consistent high-fat meal consumption and need flexible food requirements
• You prefer fixed dosing without titration adjustments
• Your physician has specific experience with Tlando and recommends it based on your medical profile

Tlando remains a viable option, particularly if insurance economics make it substantially more affordable or accessible for your situation.

Which Oral TRT Is Right for You?

For most men seeking oral testosterone replacement, Jatenzo is the superior choice based on more extensive clinical evidence, proven 2-year efficacy and safety data, titratable dosing for personalization, and demonstrated psychosexual benefits.

The main reasons to choose Tlando instead are insurance-driven (better formulary placement, lower cost) or if you genuinely cannot maintain consistent high-fat meals twice daily.

Both medications require similar commitment: twice-daily dosing with food, cardiovascular monitoring, and standard testosterone therapy follow-up. Neither offers a convenience advantage over the other in terms of dosing frequency.

Talk to Your Doctor

This comparison provides the clinical framework for decision-making, but your specific medical history, cardiovascular risk factors, and insurance coverage will ultimately determine the best choice.

Discuss both options with your physician. Ask about your insurance formulary's coverage for each medication. Request specific pricing estimates with your insurance plan before committing.

If your doctor prescribes Tlando but you're interested in Jatenzo's clinical evidence and titration capability, have that conversation. If Tlando is dramatically more affordable with your insurance, that may justify choosing it despite Jatenzo's stronger clinical data.

Finding Providers Who Prescribe Oral TRT

Not all testosterone therapy providers are equally experienced with oral formulations. Both Jatenzo and Tlando are relatively new medications (approved 2019 and 2022 respectively), and some prescribers default to familiar injection or topical options.

Look for urologists, endocrinologists, or men's health specialists who specifically mention oral TRT options in their practice descriptions. Telemedicine TRT providers are increasingly offering oral options as part of their treatment menus.

When consulting with a provider, ask directly: "Do you prescribe Jatenzo or Tlando? How many patients have you started on oral testosterone?" Experience matters for optimal dosing, monitoring, and troubleshooting.

Remember that both medications require REMS (Risk Evaluation and Mitigation Strategy) program compliance for blood pressure monitoring, meaning your provider must follow specific safety protocols. This actually works in your favor—it ensures proper cardiovascular oversight throughout treatment.

Jatenzo

Jatenzo is an oral testosterone replacement medication designed for men with low testosterone. It uses a novel delivery system that allows testosterone to be absorbed through the intestines, bypassing first-pass liver metabolism. Administered as capsules taken twice daily with food, Jatenzo offers an alternative to injections and topical treatments.

• Oral capsule format
• Twice-daily dosing
• Take with food
• Prescription required
• FDA-approved testosterone

Tlando

Tlando is an oral testosterone replacement therapy delivered as a capsule. It uses a unique delivery mechanism designed to increase testosterone absorption through the gastrointestinal tract. The medication is taken by mouth and aims to provide a convenient alternative to injections or topical applications for testosterone supplementation.

• Oral capsule format
• Prescription required
• Daily administration
• FDA-approved testosterone treatment